CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- 4 Open-market buy Chief Executive Officer bought 3,774 shares at $6.00 ($22,644)
- 4 Open-market buy President and COO bought 2,073 shares at an average $6.05 ($12,537)
- 4 Open-market buy Director bought 2,500 shares at an average $6.10 ($15,254)
- 4 Open-market buy Chief Executive Officer bought 200,000 shares at $0.35 ($70,000)
- 4 Open-market buy Chief Financial Officer bought 100,000 shares at $0.44 ($44,000)
- 4 Open-market buy Chief Executive Officer bought 261,469 shares at an average $0.40 ($104,898)
- 4 Grant or award Chief Executive Officer acquired 100,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 105,600 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 71,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and COO acquired 89,100 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 70,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Other acquisition Director acquired 10,000 shares (code O)
- 4 Other acquisition President and COO acquired 12,000 shares (code O)
- 4 Other acquisition Chief Financial Officer acquired 32,625 shares (code O)
- 4 Other acquisition Chief Executive Officer acquired 34,168 shares (code O)
- 4 Other acquisition Director acquired 21,950 shares (code O)
Page 1 of 20 · 395 filings